Han Bo, Hao Sen, Wu Jixiang, Fang Jugao, Han Zhengxue
Department of General Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, China.
Front Med (Lausanne). 2022 Sep 26;9:906648. doi: 10.3389/fmed.2022.906648. eCollection 2022.
Low-risk papillary thyroid microcarcinoma (PTMC) without clinically evident lymph nodes, extrathyroidal expansions, and distant metastases may be candidates for active monitoring.
The purpose of this research is to identify risk factors for papillary thyroid microcarcinoma (PTMC) metastasis to central cervical lymph nodes (CLNM) and to discuss the viability of an active surveillance strategy to minimize unnecessary therapy for patients.
This single-center retrospective study was conducted on the data and medical records of the patients who were diagnosed with PTMC and underwent surgery at the Baotou Cancer Hospital, China, between January 1, 2018, and December 31, 2019. Both lobectomy and complete thyroid resections were performed, and central lymph node dissections (CLND) were used in all patients. Comparisons and analyses were conducted on the preoperative ultrasound (US) characteristics, the post-operation pathological results, and lymph node metastasis.
We analyzed 172 patients with PTMC with average age 48.32 ± 10.59 years old, with 31 males and 142 females. US testing showed 74 (43.0%) patients had suspicious lymph nodes; 31 (41.9%) had capsular invasion and 52 (30.2%) patients were confirmed to have CLNM. Based on logistic regression analysis, central lymph node metastasis was shown to be more common in individuals with PTMC who were older than 45 years old, male, and had tumors that lacked micro-calcification on US imaging. Postoperative pathology assessments suggested that 58 cases (33.7%) were more suitable candidates for active surveillance cohorts.
While active surveillance might benefit many PTMC patients, treatments for the patients should also encompass occult lymph node metastasis, especially in patients with over 45 years old, male, tumor without micro-calcification in the US imaging. Furthermore, the prediction of lymph nodes in the central cervical the preoperative US and the PTMC risk stratification accuracy need to be improved. Our findings showed about 30% of the patients with PTMC had no active surveillance high-risk factors but required surgical treatment. Fear of cancer in the PTMC patients, although informed of the details, is still the main reason for choosing surgical treatment over active surveillance.
无临床明显淋巴结转移、甲状腺外侵犯及远处转移的低危甲状腺微小乳头状癌(PTMC)患者可能适合进行主动监测。
本研究旨在确定甲状腺微小乳头状癌(PTMC)发生中央区颈淋巴结转移(CLNM)的危险因素,并探讨主动监测策略对减少患者不必要治疗的可行性。
本单中心回顾性研究对2018年1月1日至2019年12月31日期间在中国包头市肿瘤医院诊断为PTMC并接受手术的患者的数据和病历进行分析。所有患者均行甲状腺叶切除术或全甲状腺切除术,并进行中央区淋巴结清扫(CLND)。对术前超声(US)特征、术后病理结果及淋巴结转移情况进行比较分析。
我们分析了172例PTMC患者,平均年龄48.32±10.59岁,其中男性31例,女性142例。超声检查显示74例(43.0%)患者有可疑淋巴结;31例(41.9%)有包膜侵犯,52例(30.2%)患者确诊有CLNM。基于逻辑回归分析,结果显示年龄大于45岁、男性且超声成像显示肿瘤无微小钙化的PTMC患者发生中央区淋巴结转移更为常见。术后病理评估表明,58例(33.7%)患者更适合纳入主动监测队列。
虽然主动监测可能使许多PTMC患者受益,但对这些患者的治疗也应包括隐匿性淋巴结转移,特别是年龄大于45岁、男性、超声成像显示肿瘤无微小钙化的患者。此外,术前超声对中央区颈淋巴结的预测以及PTMC风险分层的准确性有待提高。我们的研究结果显示,约30%的PTMC患者没有主动监测的高危因素,但仍需要手术治疗。尽管已被告知详情,但PTMC患者对癌症的恐惧仍是他们选择手术治疗而非主动监测的主要原因。